ADINA Act
This bill requires drug labels to clearly state if a medication contains major food allergens (like peanuts, dairy, or shellfish) or gluten from grains (such as wheat, barley, or rye). It applies to human drugs sold in the U.S. and mandates manufacturers to identify these specific ingredients on labels. The requirement takes effect within two years of the bill's passage, giving companies time to update packaging. This directly affects drug manufacturers and helps people with allergies make safer choices by providing clear ingredient information.
Bill status
in committee
1 of 4 stages cleared
Introduction
Jun 2025
Committee Review
Floor Vote
President
Introduced Jun 6, 2025
Last action Jun 6, 2025
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
3
Key actions
0
Committee
1
Jun 6, 2025
Committee
Referred to the House Committee on Energy and Commerce.
lower
Jun 6, 2025
Introduced
Introduced in House
lower
1 primary · 21 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Kelly Morrison
DDemocratic
Co
Addison P. McDowell
RRepublican
Co
André Carson
DDemocratic
Co
Angie Craig
DDemocratic
Co
Ben Cline
RRepublican
Co
Brian K. Fitzpatrick
RRepublican
Co
Chellie Pingree
DDemocratic
Co
Don Bacon
RRepublican
Co
Doris O. Matsui
DDemocratic
Co
Eleanor Holmes Norton
DDemocratic
Co
Eric Sorensen
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about HR 3821
Scope: US
Hi! I can help you understand HR 3821. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline